Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Cushing's disease (Signifor SC): 0.6 mg SC BID initial, titrate to 0.9 mg SC BID based on tolerability and response. Acromegaly (Signifor LAR): 40 mg IM q4wk initial, maximum 60 mg. Cushing's disease (Signifor LAR): 10 mg IM q4wk initial, maximum 40 mg.